SARS-CoV-2 3CLpro-IN-30
SARS-CoV-2 3CLpro-IN-30 (compound 29) is a potent inhibitor of SARS-CoV-2 3CL protease (SARS-CoV-2 3CLpro), with the IC50 and EC50 of 0.04 and 0.3 μM[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
N#CC1=C(C[C@@H](N)C(N[C@H](CC2=C(Cl)C=C(Cl)C=C2)C(N[C@@H](CC3=CC=C(F)C=C3)CC(NCCCC4=CC=CN=C4)=O)=O)=O)C=CC=C1
Molecular Formula
C37H37Cl2FN6O3
Molecular Weight
703.63
References & Citations
[1]Hengrui Liu, et al. Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening. Nat Commun. 2025 Jan 2;16 (1) :152.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15369749 1 Vial
Lentiviral human CCKBR sgRNA gene knockout kit - Lentiviral human CCKBR sgRNA gene knockout kit (plasmid)
Ask
View Details 
